|Mr. Ilan Danieli||Founder, Pres, CEO & Director||263.8k||N/A||1972|
|Mr. Carl R. Iberger||CFO & Sec.||208.16k||N/A||1953|
|Mr. Ahmed Zaki Sabet||Chief Operating Officer||163.69k||N/A||1986|
|Mr. Douglas Sites||VP of Sales||N/A||N/A||N/A|
|Mr. Ayman Mohamed||Sr. VP of R&D and Laboratory Operations||N/A||N/A||1985|
Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer. The company is based in New Haven, Connecticut.
Precipio, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.